特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
959784

抗緑内障薬の世界市場 - COVID-19の影響と回復:2020年~2030年

Antiglaucoma Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery

出版日: | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
抗緑内障薬の世界市場 - COVID-19の影響と回復:2020年~2030年
出版日: 2020年09月09日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の抗緑内障薬市場について調査分析し、市場の特徴、市場規模と成長、市場セグメンテーション、地域別・国別の内訳、競合情勢、市場シェア、動向と戦略について、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 抗緑内障薬市場の特徴

第3章 抗緑内障薬市場規模と成長

  • 世界の抗緑内障薬市場実績 (金額)
    • 市場促進要因
    • 市場抑制要因
  • 世界の抗緑内障薬市場予測 (金額)
    • 市場促進要因
    • 市場抑制要因

第4章 抗緑内障薬市場セグメンテーション

  • 世界の抗緑内障薬市場:製品タイプ別セグメンテーション、実績と予測 (金額)
    • アルファ作動薬
    • ベータ遮断薬
    • プロスタグランジン類似体
    • 併用薬
    • その他
  • 世界の抗緑内障薬市場:病状タイプ別セグメンテーション、実績と予測 (金額)
    • 開放隅角緑内障
    • 閉塞隅角緑内障
    • 正常眼圧緑内障
    • 先天緑内障
    • その他
  • 世界の抗緑内障薬市場:タイプ別セグメンテーション、実績と予測 (金額)
    • 病院処方薬
    • OTC薬

第5章 抗緑内障薬市場の地域別・国別分析

  • 世界の抗緑内障薬市場:地域別、実績と予測 (金額)
  • 世界の抗緑内障薬市場:国別、実績と予測 (金額)

第6章 アジア太平洋の抗緑内障薬市場

  • アジア太平洋の抗緑内障薬市場概要
  • アジア太平洋の抗緑内障薬市場:製品タイプ別セグメンテーション、実績と予測 (金額)
  • アジア太平洋の抗緑内障薬市場:病状タイプ別セグメンテーション、実績と予測 (金額)

第7章 中国の抗緑内障薬市場

  • 中国の抗緑内障薬市場概要
  • 中国の抗緑内障薬市場:製品タイプ別セグメンテーション、実績と予測 (金額)
  • 中国の抗緑内障薬市場:病状タイプ別セグメンテーション、実績と予測 (金額)

第8章 インドの抗緑内障薬市場

  • インドの抗緑内障薬市場概要
  • インドの抗緑内障薬市場:製品タイプ別セグメンテーション、実績と予測 (金額)
  • インドの抗緑内障薬市場:病状タイプ別セグメンテーション、実績と予測 (金額)

第9章 日本の抗緑内障薬市場

  • 日本の抗緑内障薬市場概要
  • 日本の抗緑内障薬市場:製品タイプ別セグメンテーション、実績と予測 (金額)
  • 日本の抗緑内障薬市場:病状タイプ別セグメンテーション、実績と予測 (金額)

第10章 オーストラリアの抗緑内障薬市場

  • オーストラリアの抗緑内障薬市場:製品タイプ別セグメンテーション、実績と予測 (金額)
  • オーストラリアの抗緑内障薬市場:病状タイプ別セグメンテーション、実績と予測 (金額)

第11章 インドネシアの抗緑内障薬市場

  • インドネシアの抗緑内障薬市場:製品タイプ別セグメンテーション、実績と予測 (金額)
  • インドネシアの抗緑内障薬市場:病状タイプ別セグメンテーション、実績と予測 (金額)

第12章 韓国の抗緑内障薬市場

  • 韓国の抗緑内障薬市場:製品タイプ別セグメンテーション、実績と予測 (金額)
  • 韓国の抗緑内障薬市場:病状タイプ別セグメンテーション、実績と予測 (金額)

第13章 西欧の抗緑内障薬市場

  • 西欧の抗緑内障薬市場概要
  • 西欧の抗緑内障薬市場:製品タイプ別セグメンテーション、実績と予測 (金額)
  • 西欧の抗緑内障薬市場:病状タイプ別セグメンテーション、実績と予測 (金額)

第14章 英国の抗緑内障薬市場

  • 英国の抗緑内障薬市場概要
  • 英国の抗緑内障薬市場:製品タイプ別セグメンテーション、実績と予測 (金額)
  • 英国の抗緑内障薬市場:病状タイプ別セグメンテーション、実績と予測 (金額)

第15章 ドイツの抗緑内障薬市場

  • ドイツの抗緑内障薬市場:製品タイプ別セグメンテーション、実績と予測 (金額)
  • ドイツの抗緑内障薬市場:病状タイプ別セグメンテーション、実績と予測 (金額)

第16章 フランスの抗緑内障薬市場

  • フランスの抗緑内障薬市場:製品タイプ別セグメンテーション、実績と予測 (金額)
  • フランスの抗緑内障薬市場:病状タイプ別セグメンテーション、実績と予測 (金額)

第17章 東欧の抗緑内障薬市場

  • 東欧の抗緑内障薬市場概要
  • 東欧の抗緑内障薬市場:製品タイプ別セグメンテーション、実績と予測 (金額)
  • 東欧の抗緑内障薬市場:病状タイプ別セグメンテーション、実績と予測 (金額)

第18章 ロシアの抗緑内障薬市場

  • ロシアの抗緑内障薬市場:製品タイプ別セグメンテーション、実績と予測 (金額)
  • ロシアの抗緑内障薬市場:病状タイプ別セグメンテーション、実績と予測 (金額)

第19章 北米の抗緑内障薬市場

  • 北米の抗緑内障薬市場概要
  • 北米の抗緑内障薬市場:製品タイプ別セグメンテーション、実績と予測 (金額)
  • 北米の抗緑内障薬市場:病状タイプ別セグメンテーション、実績と予測 (金額)

第20章 米国の抗緑内障薬市場

  • 米国の抗緑内障薬市場概要
  • 米国の抗緑内障薬市場:製品タイプ別セグメンテーション、実績と予測 (金額)
  • 米国の抗緑内障薬市場:病状タイプ別セグメンテーション、実績と予測 (金額)

第21章 南米の抗緑内障薬市場

  • 南米の抗緑内障薬市場概要
  • 南米の抗緑内障薬市場:製品タイプ別セグメンテーション、実績と予測 (金額)
  • 南米の抗緑内障薬市場:病状タイプ別セグメンテーション、実績と予測 (金額)

第22章 ブラジルの抗緑内障薬市場

  • ブラジルの抗緑内障薬市場:製品タイプ別セグメンテーション、実績と予測 (金額)
  • ブラジルの抗緑内障薬市場:病状タイプ別セグメンテーション、実績と予測 (金額)

第23章 中東の抗緑内障薬市場

  • 中東の抗緑内障薬市場概要
  • 中東の抗緑内障薬市場:製品タイプ別セグメンテーション、実績と予測 (金額)
  • 中東の抗緑内障薬市場:病状タイプ別セグメンテーション、実績と予測 (金額)

第24章 アフリカの抗緑内障薬市場

  • アフリカの抗緑内障薬市場概要
  • アフリカの抗緑内障薬市場:製品タイプ別セグメンテーション、実績と予測 (金額)
  • アフリカの抗緑内障薬市場:病状タイプ別セグメンテーション、実績と予測 (金額)

第25章 抗緑内障薬市場の競合情勢と企業プロファイル

  • 抗緑内障薬市場の競合情勢
  • 抗緑内障薬市場の企業プロファイル
    • Aerie Pharmaceuticals, Inc
    • ALLERGAN
    • Novartis AG
    • Abbott Healthcare
    • Johnson & Johnson

第26章 抗緑内障薬市場における主要なM&A

第27章 抗緑内障薬市場の動向と戦略

第28章 製品パイプライン分析

第29章 抗緑内障薬市場の将来見通しと潜在的分析

第30章 付録

目次

Antiglaucoma Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global antiglaucoma drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the antiglaucoma drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Antiglaucoma Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Product Type: Alpha Agonist; Beta Blockers; Prostaglandin Analogs; Combined Medication; Others

2) By Disease Condition Type: Open-Angle Glaucoma; Angle-Closure Glaucoma; Normal-Tension Glaucoma; Congenital Glaucoma; Other Types Of Glaucoma

3) By Type: Hospital Prescription drugs; Over-the counter drugs

Companies Mentioned: Aerie Pharmaceuticals; ALLERGAN; Novartis AG; Abbott Healthcare; Johnson & Johnson

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Antiglaucoma Drugs Market Characteristics

3. Antiglaucoma Drugs Market Size And Growth

  • 3.1. Global Antiglaucoma Drugs Historic Market, 2015-2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Antiglaucoma Drugs Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Antiglaucoma Drugs Market Segmentation

  • 4.1. Global Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Alpha Agonist
    • Beta Blockers
    • Prostaglandin Analogs
    • Combined Medication
    • Others
  • 4.2. Global Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Open-Angle Glaucoma
    • Angle-Closure Glaucoma
    • Normal-Tension Glaucoma
    • Congenital Glaucoma
    • Other Types Of Glaucoma
  • 4.3. Global Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Hospital Prescription drugs
    • Over-the counter drugs

5. Antiglaucoma Drugs Market Regional And Country Analysis

  • 5.1. Global Antiglaucoma Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Antiglaucoma Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Antiglaucoma Drugs Market

  • 6.1. Asia-Pacific Antiglaucoma Drugs Market Overview
  • 6.2. Asia-Pacific Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Antiglaucoma Drugs Market

  • 7.1. China Antiglaucoma Drugs Market Overview
  • 7.2. China Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Antiglaucoma Drugs Market

  • 8.1. India Antiglaucoma Drugs Market Overview
  • 8.2. India Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Antiglaucoma Drugs Market

  • 9.1. Japan Antiglaucoma Drugs Market Overview
  • 9.2. Japan Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Antiglaucoma Drugs Market

  • 10.1. Australia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Antiglaucoma Drugs Market

  • 11.1. Indonesia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Antiglaucoma Drugs Market

  • 12.1. South Korea Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Antiglaucoma Drugs Market

  • 13.1. Western Europe Antiglaucoma Drugs Market Overview
  • 13.2. Western Europe Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Antiglaucoma Drugs Market

  • 14.1. UK Antiglaucoma Drugs Market Overview
  • 14.2. UK Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Antiglaucoma Drugs Market

  • 15.1. Germany Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Antiglaucoma Drugs Market

  • 16.4. France Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Antiglaucoma Drugs Market

  • 17.1. Eastern Europe Antiglaucoma Drugs Market Overview
  • 17.2. Eastern Europe Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Antiglaucoma Drugs Market

  • 18.1. Russia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Antiglaucoma Drugs Market

  • 19.1. North America Antiglaucoma Drugs Market Overview
  • 19.2. North America Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Antiglaucoma Drugs Market

  • 20.1. USA Antiglaucoma Drugs Market Overview
  • 20.2. USA Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Antiglaucoma Drugs Market

  • 21.1. South America Antiglaucoma Drugs Market Overview
  • 21.2. South America Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Antiglaucoma Drugs Market

  • 22.1. Brazil Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Antiglaucoma Drugs Market

  • 23.1. Middle East Antiglaucoma Drugs Market Overview
  • 23.2. Middle East Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Antiglaucoma Drugs Market

  • 24.1. Africa Antiglaucoma Drugs Market Overview
  • 24.2. Africa Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Antiglaucoma Drugs Market Competitive Landscape And Company Profiles

  • 25.1. Antiglaucoma Drugs Market Competitive Landscape
  • 25.2. Antiglaucoma Drugs Market Company Profiles
    • 25.2.1. Aerie Pharmaceuticals, Inc
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. ALLERGAN
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Novartis AG
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Abbott Healthcare
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Johnson & Johnson
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Antiglaucoma Drugs Market

27. Antiglaucoma Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Antiglaucoma Drugs Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.